BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3216605)

  • 21. [Non-enzymatic glycosylation of proteins. Complications of diabetes mellitus, aging and kidney failure].
    Monnier V
    Presse Med; 1993 Oct; 22(30):1413-8. PubMed ID: 8248084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poor glycemic control associates with high intravitreal angiopoietin-2 levels in patients with diabetic retinopathy.
    Tuuminen R; Haukka J; Loukovaara S
    Acta Ophthalmol; 2015 Sep; 93(6):e515-6. PubMed ID: 24697902
    [No Abstract]   [Full Text] [Related]  

  • 23. Green tea attenuates diabetes induced Maillard-type fluorescence and collagen cross-linking in the heart of streptozotocin diabetic rats.
    Babu PV; Sabitha KE; Srinivasan P; Shyamaladevi CS
    Pharmacol Res; 2007 May; 55(5):433-40. PubMed ID: 17336542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced Maillard reaction and crosslinking of corneal collagen in diabetes.
    Sady C; Khosrof S; Nagaraj R
    Biochem Biophys Res Commun; 1995 Sep; 214(3):793-7. PubMed ID: 7575546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The oxidative stress in the development of diabetes chronic complications in the elderly.
    Suciu I; Negrean V; Sâmpelean D
    Rom J Intern Med; 2004; 42(2):395-406. PubMed ID: 15529629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced glycation end-products: a review.
    Singh R; Barden A; Mori T; Beilin L
    Diabetologia; 2001 Feb; 44(2):129-46. PubMed ID: 11270668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy.
    Matsuyama K; Ogata N; Matsuoka M; Shima C; Wada M; Jo N; Matsumura M
    Mol Vis; 2008 May; 14():992-6. PubMed ID: 18523656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of glycation-induced browning in lens crystallins. A simple method for studying the advanced products of the Maillard reaction.
    Vidal P; Cabezas-Cerrato J
    Ophthalmic Res; 1989; 21(3):261-7. PubMed ID: 2779978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycosylated hemoglobin, glycemic control, and mortality in hemodialyzed diabetic patients.
    Rambod M; Broumand B
    Kidney Int; 2007 May; 71(10):1078. PubMed ID: 17495942
    [No Abstract]   [Full Text] [Related]  

  • 30. The biochemistry of the complications of diabetes mellitus.
    Brownlee M; Cerami A
    Annu Rev Biochem; 1981; 50():385-432. PubMed ID: 6168237
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiovascular disease, neuropathy, and retinopathy.
    Bloomgarden ZT
    Diabetes Care; 2009 Jun; 32(6):e64-8. PubMed ID: 19460904
    [No Abstract]   [Full Text] [Related]  

  • 32. Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis.
    Tessier F; Obrenovich M; Monnier VM
    J Biol Chem; 1999 Jul; 274(30):20796-804. PubMed ID: 10409619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effects of tenilsetam on the Maillard reaction.
    Shoda H; Miyata S; Liu BF; Yamada H; Ohara T; Suzuki K; Oimomi M; Kasuga M
    Endocrinology; 1997 May; 138(5):1886-92. PubMed ID: 9112383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal validation of hemoglobin A(1c) criteria for diabetes diagnosis: risk of retinopathy.
    Sobrin L
    Diabetes; 2012 Dec; 61(12):3074-5. PubMed ID: 23172958
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic performance of glycated hemoglobin for diabetic retinopathy in non-diabetic older overweight/obese African-Americans.
    Okosun IS; Turbow S; McJenkin K; Monique Davis-Smith Y; Seale JP
    Diabetes Res Clin Pract; 2016 Oct; 120():124-31. PubMed ID: 27544907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinal vascular caliber as a biomarker for diabetes microvascular complications.
    Ikram MK; Cheung CY; Lorenzi M; Klein R; Jones TL; Wong TY;
    Diabetes Care; 2013 Mar; 36(3):750-9. PubMed ID: 23431093
    [No Abstract]   [Full Text] [Related]  

  • 38. Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes.
    Virk SA; Donaghue KC; Cho YH; Benitez-Aguirre P; Hing S; Pryke A; Chan A; Craig ME
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3257-63. PubMed ID: 27186858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycosylation of proteins: its implications in diabetic control and complications.
    Kirschenbaum DM
    Pediatr Clin North Am; 1984 Jun; 31(3):611-21. PubMed ID: 6374590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.
    McCance DR; Dyer DG; Dunn JA; Bailie KE; Thorpe SR; Baynes JW; Lyons TJ
    J Clin Invest; 1993 Jun; 91(6):2470-8. PubMed ID: 8514859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.